All posts from Zacks
Zacks in Our Research. Your Success.,

SolarEdge (SEDG) and Teva (TEVA) are Blowouts!

SolarEdge (SEDG) has reported back to back big beats, the most recent one was a blowout.  Brian Bolan notes that revenue guidance was much better than expected and there is an indication that margins might surprise to the upside as well.  Brian kills us at the end of the segment with a horrible solar stock pun.  Teva Pharma (TEVA) is being blown off the books  after a big miss and weak guidance.  Brian touches on an industry that is particularly hard hit by the opioid crisis and let’s those afflicted by it know there is help available for them.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Teva Pharmaceutical Industries Limited (TEVA): Free Stock Analysis Report
SolarEdge Technologies, Inc. (SEDG): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research